JP2009268922A5 - - Google Patents

Info

Publication number

JP2009268922A5

JP2009268922A5 JP2009188465A JP2009188465A JP2009268922A5 JP 2009268922 A5 JP2009268922 A5 JP 2009268922A5 JP 2009188465 A JP2009188465 A JP 2009188465A JP 2009188465 A JP2009188465 A JP 2009188465A JP 2009268922 A5 JP2009268922 A5 JP 2009268922A5

Authority

JP

Japan

Prior art keywords

dialysis fluid

concentration

fluid

dialyzer

substance

Prior art date

2009-08-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000385 dialysis solution Substances 0.000 claims 29
• 239000012530 fluid Substances 0.000 claims 18
• 239000000126 substance Substances 0.000 claims 13
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 9
• 238000000034 method Methods 0.000 claims 9
• 239000004202 carbamide Substances 0.000 claims 6
• CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims 6
• 239000012528 membrane Substances 0.000 claims 6
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 3
• 229930003779 Vitamin B12 Natural products 0.000 claims 3
• 102000015736 beta 2-Microglobulin Human genes 0.000 claims 3
• 108010081355 beta 2-Microglobulin Proteins 0.000 claims 3
• FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 3
• 229960003624 creatine Drugs 0.000 claims 3
• 239000006046 creatine Substances 0.000 claims 3
• 239000008103 glucose Substances 0.000 claims 3
• 150000002500 ions Chemical class 0.000 claims 3
• 229940045136 urea Drugs 0.000 claims 3
• 239000011715 vitamin B12 Substances 0.000 claims 3
• 235000019163 vitamin B12 Nutrition 0.000 claims 3
• 239000008280 blood Substances 0.000 claims 2
• 210000004369 blood Anatomy 0.000 claims 2
• 230000017531 blood circulation Effects 0.000 claims 2
• 230000007423 decrease Effects 0.000 claims 2
• 238000000502 dialysis Methods 0.000 claims 2
• 238000012544 monitoring process Methods 0.000 claims 2
• 238000007599 discharging Methods 0.000 claims 1